Dennis R. Leahy, MD, shares his POV on the value of making Lp(a) testing universal, not only to inform patients and their clinicians of the high CV risks, but to make way for potential treatments.
The evidence implicating high levels of lipoprotein(a), or Lp(a), as a risk predictor for heart attack, stroke, and other cardiovascular conditions has outpaced the science of what to do about the ...
Researchers from University of California San Diego School of Medicine have found that testing for lipoprotein(a) — a genetic risk factor for heart disease — remains uncommon in the United States, ...
A new study has drawn attention to inaccurate measurement of LDL-cholesterol levels in some patients with current assays, which could lead to incorrect therapeutic approaches. The patient groups most ...
NEW YORK--(BUSINESS WIRE)--LetsGetChecked, a global healthcare solutions company, today announced its collaboration with Novartis to increase access to Lipoprotein(a)–Lp(a)–testing and programs. Now, ...
Hosted on MSN
THIS overlooked blood test could expose the real cause of heart attacks in people who seem perfectly healthy
Most health-conscious people closely track their cholesterol, blood sugar, and blood pressure, but cardiologists are now highlighting another vital yet often ignored heart health factor, Lipoprotein(a ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The Skeptical ...
Please provide your email address to receive an email when new articles are posted on . A lipoprotein(a) assay received breakthrough device designation from the FDA. The assay is designed to aid in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results